一种基于纳米平台的新型circCSNK1G3影响CBX7蛋白并促进质瘤细胞生长
Cheng-Jie Qiu1, Liang-Yun Hu1, Jin Yang2
1Department of Neurosurgery, Rui-Jin Hospital, Shanghai Jiao-Tong University, School of Medicine, Shanghai, China.
International journal of biological macromolecules
|July 21, 2024
概括
循环RNA circCSNK1G3通过稳定miR-181和抑制CBX7.7促进质瘤生长. 抑制circCSNK1G3显示出质瘤治疗的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 质瘤的发展可能涉及生物环境和生物因素.
- 循环RNAcircCSNK1G3与促进质瘤细胞生长有关.
- circCSNK1G3通过稳定miR-181和降低瘤抑制剂CBX7的调节来影响质瘤.
研究的目的:
- 为了研究circCSNK1G3在质瘤中的作用.
- 探索circCSNK1G3在质瘤进展中的功能机制.
- 评估球瘤中准circCSNK1G3的治疗潜力.
主要方法:
- 使用腺相关病毒 (AAV) -RNAi纳米平台进行研究.
- 使用siRNA来沉默circCSNK1G3的表达.
- 引入了miR-181d模仿剂和抑制剂,以研究调节相互作用.
- 在质瘤细胞中过度表达的circCSNK1G3.
- 使用A172异种移植评估了瘤生长抑制.
主要成果:
- 沉默cirCSNK1G3降低了miR-181d,并增加了CBX7的表达.
- miR-181d模仿剂逆转了circCSNK1G3沉默的抗质瘤作用.
- 抑制miR-181d模仿了circCSNK1G3的沉默效应.
- 过度表达circCSNK1G3导致miR-181d升高和CBX7.7降低.
- circCSNK1G3小RNA显著抑制了A172异种移植的生长.
结论:
- circCSNK1G3在质瘤中充当致癌的循环RNA.
- 环CSNK1G3/miR-181d/CBX7轴是质瘤进展的一个关键途径.
- 向circCSNK1G3表明了质瘤治疗的治疗潜力.
相关概念视频
The Nucleolus
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...


